Login

Introducing YESCan: Streamlining Fenestration Product Data Submission to NRCan | Valmor Ruscheck - CEO of Natural Resources Canada 00:10:00

Share On Facebook Share On Twitter

Valmor Ruscheck is the CEO of Natural Resources Canada

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
The worlds largest portfolio of marketplace startups|Fabrice Grinda,Founding Partner,FJ Labs
00:10:00
Explore the unknown abyss and uncover its enigmatic wonders |William H. Rogers Jr, Chairman ,  Truist Financial.
00:10:00
Travel Trends & Hybrid Work: Insights from BLADE's CEO | Robert S Wiesenthal - CEO of Blade Air Mobility Inc.
00:10:00
Choosing Wilson Sonsini: Insights from Our Team
00:10:00
Inspiring Conversations: Gale Force Wins Podcast| Matt Adams - CEO of NetBenefit Software
00:10:00
Aris Mining: Transformational Growth and High-Grade Assets in Colombia
00:00:00
Alyx B. Porter, M.D. Neurologist, Mayo Clinic / Are all brain tumors cancerous : Ask Mayo Clinic
00:10:00
Energy Company Focused on Generation, Retail, Trading, and Fuel Development | Marc England, CEO , Genesis Energy ltd.
00:10:00
Hakan Koç and Marco Rodzynek Discuss AUTO1 Group's Global Expansion and Innovation Strategies | Hakan Koç , Chairman, Auto1 Group SE.
00:10:00
Exploring Gold Opportunities: Key Insights from Orange's Major Exploration Projects
00:10:00
Hakan Koç Discusses Auto1's Vision and the Future of Digital Car Sales | Hakan Koç , Chairman, Auto1 Group SE.
00:10:00
SuperReturn International hosts Steve Klinsky from New Mountain Capital and Jake Elmhirst from UBS for discussions on investment strategies and market trends.

© 2026 Nehu